Currently, John serves as CEO and board member of UroCure, LLC, a healthcare company he co-founded. Amid the challenges of the global pandemic, he led the company in raising $9 million and successfully developing and launching three innovative slings for the treatment of female stress urinary incontinence. He also secured a strategic partnership with a European company which provided growth capital and commercial synergies. Under his leadership, UroCure introduced a series of operational and service innovations that strengthened the brand, reduced enterprise risk and enhanced the company’s commercial model.
Before UroCure, John served as a strategic advisor to PE and VC firms and emerging company boards. He originated and led diligence on a $100M carve-out opportunity with Warburg Pincus. He was also engaged by the board of an Israeli medical device company to develop a US commercialization and fundraising strategy.
Prior, John revitalized KSpine, Inc., a venture-funded medical device company developing novel surgical technology for scoliosis. Recruited by leading VC firms, he redefined the company’s market offering, led a 12-month global fundraising and strategic alternative process that culminated in an asset sale to K2M.
John’s tenure at American Medical Systems (AMS) reflects his extraordinary capability to drive organizational transformation at scale. Serving in multiple senior leadership roles over 11 years, he led the Women’s Health business through a period of accelerated growth, achieving top market share in the pelvic floor segment and ultimately contributing to a successful $2.9 billion acquisition by Endo International. His leadership in strategic corporate development, including M&A activity and global regulatory alignment, positioned AMS as a double-digit growth market leader with an operating margin of 28 percent.
In addition to corporate leadership, John has consistently focused on developing talent and cultivating leadership pipelines within the organizations he serves. He is deeply committed to succession planning, mentoring, and ensuring that capable leaders are prepared to navigate future challenges. His approach to leadership emphasizes collaboration, empowerment, and the alignment of organizational strategy with operational execution.
John is widely recognized for his ability to establish and nurture complex strategic partnerships. He has successfully negotiated alliances, joint ventures, and collaborations that have delivered substantial value for all parties. His approach is characterized by a win-win mindset, creative problem-solving, and a focus on long-term sustainability, which has repeatedly resulted in accelerated growth, expanded market presence, and enhanced shareholder value.
Throughout his career, John has also maintained a strong presence in corporate and nonprofit governance. He currently serves on the boards of UroCure and the InnerCity Tennis Foundation, where he chairs the Northside Expansion Committee. Known for providing thoughtful, authentic, and actionable insights, John excels at guiding board-level discussions and advising executive teams on strategic opportunities, risk management, and enterprise-wide decision-making.
John’s educational foundation includes a Master of Management (MBA) from the Kellogg School of Management at Northwestern University and a Bachelor of Science in Chemical Engineering from Northwestern University. He has complemented his academic training with executive leadership development at the GE Management Development Institute, reinforcing his ability to integrate technical, operational, and strategic expertise in high-stakes environments.
Outside of his professional endeavors, John is an avid athlete and outdoor enthusiast, enjoying cycling, alpine and Nordic skiing, tennis, and endurance sports including marathons and triathlons. His personal pursuits reflect the same dedication, discipline, and commitment to excellence that characterize his professional achievements, providing a holistic balance to his career in leadership and innovation.
Character:
John consistently demonstrates integrity, authenticity, and accountability in every professional endeavor. He leads by example and inspires trust among colleagues, partners, and stakeholders. His steadfast commitment to ethical decision-making underpins his approach to corporate leadership.
Knowledge:
With extensive experience across medical devices, healthcare, and regulated industries, John possesses a deep understanding of global markets, regulatory landscapes, and enterprise risk management. His technical expertise, combined with strategic insight, allows him to navigate complex challenges with precision. He continuously leverages his knowledge to drive growth and operational excellence.
Strategic:
John has a proven ability to envision and execute long-term strategies that accelerate growth and create value. He excels at identifying opportunities, structuring partnerships, and orchestrating transformative change. His foresight and analytical rigor ensure that organizations remain agile, competitive, and positioned for success.
Communication:
John is an articulate and persuasive communicator, capable of engaging diverse audiences from boards to global teams. He synthesizes complex information into actionable insights and fosters open, collaborative dialogue. His communication style promotes clarity, alignment, and decisive action across all organizational levels.
